Capsule formulations of n-tert-butyl-3-(5-methyl-2-{4-(2-pyrrolidin-1-ylethoxy)phenylamino}pyrimidin-4-yl)aminobenzenesulfonamide and use thereof in the preparation of medicaments for treating myelofibrosis

摘要

Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.